Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-006909
Filing Date
2015-12-21
Accepted
2015-12-21 06:07:22
Documents
1
Period of Report
2015-12-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4sherrington.html 4  
1 OWNERSHIP DOCUMENT form4sherrington.xml 4 3995
  Complete submission text file 0001171843-15-006909.txt   5371
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
ROBIN SHERRINGTON (Reporting) CIK: 0001619962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 151298155